`
`
`
`Keith J. Miller
`ROBINSON MILLER LLC
`One Newark Center, 19th Floor
`Newark, New Jersey 07102
`(973) 690-5400 (Telephone)
`(973) 466-2760 (Facsimile)
`
`Attorneys for Plaintiffs BTG International Ltd.,
`Janssen Biotech, Inc. Janssen Oncology, Inc., and
`Janssen Research & Development, LLC
`
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF NEW JERSEY
`
`
`
`
`Document Filed Electronically
`
`Return Date: April 4, 2016
`
`Oral Argument Requested
`
`
`
`NOTICE OF PLAINTIFF JANSSEN’S
`
`MOTION TO SET A HEARING AND
`CORRECT INVENTORSHIP OF U.S.
`PATENT NO. 8,822,438 PURSUANT
`TO 35 U.S.C. § 256
`
`
`
`
`BTG INTERNATIONAL LIMITED,
`JANSSEN BIOTECH, INC., JANSSEN
`ONCOLOGY, INC., JANSSEN RESEARCH
`& DEVELOPMENT, LLC,
`
`Plaintiffs,
`
`
`
`v.
`
`ACTAVIS LABORATORIES FL, INC.,
`AMNEAL PHARMACEUTICALS LLC,
`AMNEAL PHARMACEUTICALS OF NEW
`YORK, LLC, APOTEX CORP., APOTEX
`INC., CITRON PHARMA LLC, DR.
`REDDY'S LABORATORIES, INC., DR.
`REDDY'S LABORATORIES, LTD.,
`MYLAN PHARMACEUTICALS INC.,
`MYLAN, INC., PAR PHARMACEUTICAL,
`INC., PAR PHARMACEUTICAL
`COMPANIES, INC., SUN
`PHARMACEUTICALS INDUSTRIES, LTD.,
`SUN PHARMACEUTICALS INDUSTRIES,
`INC., TEVA PHARMACEUTICALS USA,
`INC., WEST-WARD PHARMACEUTICALS
`CORP., HIKMA PHARMACEUTICALS,
`LLC, WOCKHARDT BIO AG,
`WOCKHARDT USA LLC, WOCKHARDT
`LTD., HETERO USA INC., HETERO LABS
`LIMITED UNIT-V, and HETERO LABS
`LIMITED,
`
`
`Defendants.
`
`
`
`
`
`
`
`)
`)
`)
`)
`)
`
`)
`
`)
`) Civil Action No.:
`) 2:15-cv-05909-KM-JBC
`)
`
`)
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`
`
`Amerigen Exhibit 1099
`Amerigen v. Janssen IPR 2016-00286
`
`
`
`Case 2:15-cv-05909-KM-JBC Document 176 Filed 03/08/16 Page 2 of 4 PageID: 1906
`
`
`
`TO ALL COUNSEL OF RECORD:
`
`PLEASE TAKE NOTICE that, on April 4, 2016, or as soon thereafter as the Court
`
`deems appropriate, Plaintiffs Janssen Biotech, Inc. (“Janssen Biotech”), Janssen Oncology, Inc.
`
`(“Janssen Oncology”), and Janssen Research & Development, LLC (“Janssen R&D”)
`
`(collectively, “Janssen”) shall move before the Honorable Kevin McNulty, United States District
`
`Judge, sitting at the Martin Luther King Federal Building & U.S. Courthouse, 50 Walnut Street,
`
`Newark, New Jersey, for the entry of an Order pursuant to 35 U.S.C. § 256(b), for an Order
`
`directing the United States Patent and Trademark Office (“USPTO”) to issue a certificate
`
`correcting inventorship of U.S. Patent No. 8,822,438 (“‘438 patent”) in order to add Dr. Johann
`
`S. de Bono (“Dr. de Bono”) as an inventor, and for leave to file a Second Amended Complaint.
`
`Upon motion, the Court may correct inventorship on “notice and hearing of all parties
`
`concerned,” i.e., the omitted inventor, named inventor, and assignees of the patent, but not to
`
`accused infringers. Nichols Institute of Diagnostics, Inc. v. Scantibodies Clinical Lab., Inc., 218
`
`F. Supp. 2d 1243, 1250 (S.D. Cal. 2002). Here, three of the concerned parties, Dr. de Bono,
`
`BTG International Ltd. (the owner of Dr. de Bono’s inventions) and Janssen (the current
`
`assignee) consent to the inventorship change. Notice is being concurrently given to the two
`
`named inventors, and Janssen also has no reason to believe that the two named inventors will
`
`oppose the proposed correction. Accordingly, the Court should order correction of the ‘438
`
`patent to include Dr. de Bono.
`
`PLEASE TAKE FURTHER NOTICE that Janssen shall rely upon the accompanying
`
`Brief, Declaration of Keith J. Miller, and all papers submitted herewith.
`
`PLEASE TAKE FURTHER NOTICE that a proposed form of order is submitted
`
`herewith.
`
`
`
`2
`
`
`
`Case 2:15-cv-05909-KM-JBC Document 176 Filed 03/08/16 Page 3 of 4 PageID: 1907
`
`
`
`PLEASE TAKE FURTHER NOTICE that oral argument is requested if the Court so
`
`requires.
`
`
`
`Dated: March 8, 2016
`
`Respectfully submitted,
`
`
`
`
`
`
`s/ Keith J. Miller
`Donald A. Robinson (drobinson@rwmlegal.com)
`Keith J. Miller (kmiller@rwmlegal.com)
`Justin T. Quinn (jquinn@rwmlegal.com)
`ROBINSON MILLER LLC
`One Newark Center, 19th Floor
`Newark, New Jersey 07102
`(973) 690-5400 (Telephone)
`(973) 466-2760 (Facsimile)
`
`Attorneys for Plaintiffs BTG International Ltd.,
`Janssen Biotech, Inc., Janssen Oncology, Inc. and
`Janssen Research & Development, LLC
`
`
`
`
`
`3
`
`
`
`Case 2:15-cv-05909-KM-JBC Document 176 Filed 03/08/16 Page 4 of 4 PageID: 1908
`
`
`
`Of Counsel:
`
`Attorneys for Plaintiffs Janssen Biotech, Inc.,
`Janssen Oncology, Inc. and
`Janssen Research & Development, LLC
`
`David T. Pritikin (dpritikin@sidley.com)
`H. Ashley Chi (hchi@sidley.com)
`SIDLEY AUSTIN LLP
`1. S. Dearborn Street
`Chicago, Illinois 60603
`Tel: (312) 853-7000
`Fax: (312) 853-7036
`
`Bindu Donovan (bdonovan@sidley.com)
`S. Isaac Olson (iolson@sidley.com)
`Jesselyn C. Pe (jpe@sidley.com)
`Alyssa B. Monsen (amonsen@sidley.com)
`SIDLEY AUSTIN LLP
`787 Seventh Avenue
`New York, New York 10019
`Tel: (212) 839-5300
`Fax: (212) 839-5599
`
`Attorneys for Plaintiff BTG International Ltd.
`
`Anthony C. Tridico
`(anthony.tridico@finnegan.com)
`Jennifer H. Roscetti
`(jennifer.roscetti@finnegan.com)
`FINNEGAN, HENDERSON, FARABOW,
`GARRETT & DUNNER, LLP
`901 New York Avenue, N.W.
`Washington D.C. 20001
`Tel: (202) 408-4000
`Fax: (202) 408-4400
`
`
`
`
`
`4